Philipp Sander,
| Scripps Research Institute | # of Grants: 1 | 
Grants
      
      
      | Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 | 
| Cancer | Dissertation Awards | |
Publications 
     
            | Research Portfolio | 
| Funding Opportunities | 
| Scripps Research Institute | # of Grants: 1 | 
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 | 
| Cancer | Dissertation Awards | |